These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 2960790)

  • 1. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products.
    Brandau W; Bubeck B; Eisenhut M; Taylor DM
    Int J Rad Appl Instrum A; 1988; 39(2):121-9. PubMed ID: 2833469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
    Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
    Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR; Kasina S; Eshima D; Johnson DL
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
    Eshima D; Taylor A
    Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
    Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
    J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F; Laznicek M; Laznickova A
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A; Eshima D; Christian PE; Milton W
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
    Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
    Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension.
    Lee HB; Blaufox MD
    J Nucl Med; 1989 May; 30(5):666-71. PubMed ID: 2523959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-MAG3 kinetics in the normal pig. A comparison to 131I-OIH and 125I-iothalamate after single injection and during continuous infusion.
    Rehling M; Frøkiaer J; Poulsen EU; Marqversen J; Nielsen BV; Bacher T
    Clin Physiol; 1995 Jan; 15(1):57-71. PubMed ID: 7712693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
    Müller-Suur R; Bois-Svensson I; Mesko L
    J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of technetium-99m-MAG3 in humans.
    Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
    J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.